Document Detail

Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa.
MedLine Citation:
PMID:  7022259     Owner:  NLM     Status:  MEDLINE    
Lisuride hydrogen maleate, a semisynthetic ergoline and potent central dopamine and serotonin agonist, was tested in 10 patients with moderate to marked Parkinson disease whose response to levodopa had diminished. In the group of 10 patients, there was a significant reduction (p less than or equal to 0.05) in bradykinesia, gait disorder, and total Parkinson disease disability score when levodopa was replaced with lisuride. The mean dose of lisuride was 3.6 mg per day. Among the 10 patients, 5 were better on lisuride than on levodopa, and 4 continue on lisuride 1 year later. A decline in efficacy was noted in all four after a mean of 45 months. Adverse effects necessitating discontinuing the drug were mental changes in three patients and nausea in one patient. Lisuride, when used alone, has definite antiparkinsonian activity and is a promising new drug.
A Lieberman; M Goldstein; A Neophytides; M Kupersmith; M Leibowitz; N Zasorin; R Walker; D Kleinberg
Related Documents :
21240969 - Role of parathyroid hormone monitoring during parathyroidectomy.
25269039 - Antimicrobial prophylaxis at the neurosurgical department of a major hospital in china:...
11091289 - Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report.
10168039 - A multinational investigation of the impact of subcutaneous sumatriptan. i: design, met...
21538789 - Serial intravascular ultrasound analysis comparing double kissing (dk) and classical cr...
20533599 - Segmental duodenectomy for gastrointestinal stromal tumor of the duodenum.
10415219 - Recurrent tips failure associated with biliary fistulae: treatment with ptfe-covered st...
23797929 - The effect of range of motion after single-level discover cervical artificial disk repl...
24638649 - Efficacy of bronchoscopic closure of bronchopleural fistula with amplatzer devices: lon...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Neurology     Volume:  31     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  1981 Aug 
Date Detail:
Created Date:  1981-10-25     Completed Date:  1981-10-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  961-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Trials as Topic
Double-Blind Method
Ergolines / therapeutic use*
Levodopa / therapeutic use*
Lisuride / adverse effects,  therapeutic use*
Middle Aged
Parkinson Disease / diagnosis,  drug therapy*
Reg. No./Substance:
0/Ergolines; 0/Levodopa; 18016-80-3/Lisuride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intravenous digital subtraction angiography: application to cerebrovascular surgery.
Next Document:  Syncope problem solved by continuous ambulatory simultaneous EEG/ECG recording.